• Home
  • Ponatinib: targeting the T315I mutation in chronic myelogenous leukemia.

Ponatinib: targeting the T315I mutation in chronic myelogenous leukemia.

Author List
Shah NP
Publication
Clinical advances in hematology & oncology : H&O
Publication ID (Profile URL)
https://researcherprofiles.org/profile/227298035
Publication Year
2011
PubMed ID
22252660
Publication Title
Shah NP. Ponatinib: targeting the T315I mutation in chronic myelogenous leukemia. Clin Adv Hematol Oncol. 2011 Dec; 9(12):925-6.